Literature DB >> 26308737

Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells.

Elżbieta Boratyn1, Iwona Nowak1, Irena Horwacik1, Małgorzata Durbas1, Anna Mistarz1, Magdalena Kukla2, Przemysław Kaczówka1, Maria Łastowska3, Jolanta Jura2, Hanna Rokita1.   

Abstract

The recently discovered MCPIP1 (monocyte chemoattractant protein-induced protein 1), a multidomain protein encoded by the MCPIP1 (ZC3H12A) gene, has been described as a new differentiation factor, a ribonuclease, and a deubiquitination-supporting factor. However, its role in cancer is poorly recognized. Our recent analysis of microarrays data showed a lack of expression of the MCPIP1 transcript in primary neuroblastoma, the most common extracranial solid tumor in children. Additionally, enforced expression of the MCPIP1 gene in BE(2)-C cells caused a significant decrease in neuroblastoma proliferation and viability. Aim of the present study was to further investigate the role of MCPIP1 in neuroblastoma, using expression DNA microarrays and microRNA microarrays. Transient transfections of BE(2)-C cells were used for overexpression of either wild type of MCPIP1 (MCPIP1-wt) or its RN-ase defective mutant (MCPIP1-ΔPIN). We have analyzed changes of transcriptome and next, we have used qRT-PCR to verify mRNA levels of selected genes responding to MCPIP1 overexpression. Additionally, protein levels were determined for some of the selected genes. The choline transporter, CTL1, encoded by the SLC44A1 gene, was significantly repressed at the specific mRNA and protein levels and most importantly this translated into a decreased choline transport in MCPIP1-overexpressing cells. Then, we have found microRNA-3613-3p as the mostly altered in the pools of cells overexpressing the wild type MCPIP1. Next, we analyzed the predicted targets of the miR-3613-3p and validated them using qRT-PCR and western blot. These results indicate that the expression of miR-3613-3p might be regulated by MCPIP1 by cleavage of its precursor form.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  EXPRESSION MICROARRAYS; MONOCYTE CHEMOATTRACTANT PROTEIN-INDUCED PROTEIN 1 (ZC3H12A); NEUROBLASTOMA; PIN DOMAIN; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26308737     DOI: 10.1002/jcb.25354

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

Review 1.  Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses.

Authors:  Renfang Mao; Riyun Yang; Xia Chen; Edward W Harhaj; Xiaoying Wang; Yihui Fan
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

2.  MiR-3613-3p inhibits hypertrophic scar formation by down-regulating arginine and glutamate-rich 1.

Authors:  Lisha Li; Weiqiang Han; Yun Chen; Yuhua Chen
Journal:  Mol Cell Biochem       Date:  2020-11-09       Impact factor: 3.396

3.  MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.

Authors:  Zhaozhou Ren; Ming He; Tao Shen; Kejia Wang; Qingjie Meng; Xiangxu Chen; Long Zhou; Yanshuo Han; Chao Ji; Shengnan Liu; Qin Fu
Journal:  Cancer Biol Ther       Date:  2019-11-12       Impact factor: 4.742

4.  MCPIP1 contributes to clear cell renal cell carcinomas development.

Authors:  Janusz Ligeza; Paulina Marona; Natalia Gach; Barbara Lipert; Katarzyna Miekus; Waclaw Wilk; Janusz Jaszczynski; Andrzej Stelmach; Agnieszka Loboda; Jozef Dulak; Wojciech Branicki; Janusz Rys; Jolanta Jura
Journal:  Angiogenesis       Date:  2017-02-14       Impact factor: 9.596

5.  RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line.

Authors:  Agata Lichawska-Cieslar; Roza Pietrzycka; Janusz Ligeza; Maria Kulecka; Agnieszka Paziewska; Agata Kalita; Dobrochna D Dolicka; Mateusz Wilamowski; Katarzyna Miekus; Jerzy Ostrowski; Michal Mikula; Jolanta Jura
Journal:  Oncotarget       Date:  2018-01-16

6.  Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3.

Authors:  Annalisa Schaub; Alisha N Jones; Christian Schulz; Mathias Heikenwalder; Matthias von Gamm; Christine Wolf; Gesine Behrens; Johannes Lichti; Katharina Essig; Anna Macht; Joachim Pircher; Andreas Ehrlich; Kathrin Davari; Dhruv Chauhan; Benjamin Busch; Wolfgang Wurst; Regina Feederle; Annette Feuchtinger; Matthias H Tschöp; Caroline C Friedel; Stefanie M Hauck; Michael Sattler; Arie Geerlof; Veit Hornung; Vigo Heissmeyer; Elke Glasmacher
Journal:  J Exp Med       Date:  2019-05-24       Impact factor: 14.307

Review 7.  Activity of MCPIP1 RNase in tumor associated processes.

Authors:  Katarzyna Miekus; Jerzy Kotlinowski; Agata Lichawska-Cieslar; Janusz Rys; Jolanta Jura
Journal:  J Exp Clin Cancer Res       Date:  2019-10-21

8.  Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib.

Authors:  Yuanhang Yu; Han Liao; Rong Xie; Yue Zhang; Renjing Zheng; Jianying Chen; Bo Zhang
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

Review 9.  MCPIP1 RNase and Its Multifaceted Role.

Authors:  Richard Musson; Weronika Szukała; Jolanta Jura
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

10.  MCPIP1 ribonuclease can bind and cleave AURKA mRNA in MYCN-amplified neuroblastoma cells.

Authors:  Iwona Nowak; Elżbieta Boratyn; Sebastian Student; Stephan F Bernhart; Jörg Fallmann; Małgorzata Durbas; Peter F Stadler; Hanna Rokita
Journal:  RNA Biol       Date:  2020-08-20       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.